Neuralink

Headlines · 2

1. 6d
   Science Corporation implants PRIMA vision chip in first Stargardt patient

   Science Corporation said at TechCrunch Disrupt that its vision-restoring chip, PRIMA, has been implanted in its first patient with Stargardt disease, an inherited eye disease that destroys central vision; the procedure took place in May at the Sydney Eye Hospital in Australia as part of an ongoing trial. A roughly 2-by-2-millimeter chip is placed where photoreceptors have degenerated, and patients wear camera-equipped glasses; during the first rehabilitation session the patient saw a letter, and in the second could read a word. The company says PRIMA is already commercially available in Europe for geographic atrophy, an advanced form of age-related macular degeneration, and it believes the approach can extend to Stargardt disease, which affects about 150,000 people worldwide who have lost vision. CEO Max Hodak, a former Neuralink president and co-founder, said a next-generation implant should reach human testing within a year and that the company hopes to approach native acuity over about five years.

   TechCrunch AI · 🔥 0
2. Oct 7
   Bridge Neurotech Raises $13.5M for Ultrasound BCI

   Bridge Neurotech has emerged from stealth with $13.5 million to develop a non-invasive brain-computer interface that uses functional ultrasound imaging to measure brain activity through the skull. The startup also signed a multi-year technology and hardware agreement with Butterfly Network, while its first human study is enrolling healthy adults in California.

   The Next Web · 🔥 0

Experience and discussion from the community

Share my Neuralink experienceAsk about Neuralink